Myocardial delivery of MMP inhibiting hydrogels

Ended Project Grant Awarded Last action

Award ID
R44HL140645
Recipient
Awarding agency
Obligated
$4,323,444

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Funding
  • $3,200,596.00 Federal
  • $1,122,848.00 Non-federal
Place of performance
Pennsylvania, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $100,750 $0
Amendment $100,750 $100,750
Amendment $994,660 $0
Amendment $994,660 $994,660
Amendment $0 $0
Amendment $0 $0
Amendment $27,438 $0
Amendment $27,438 $27,438
Original award $954,900 $0
Show all 11

Quick answers

Who received award R44HL140645?

R44HL140645 was awarded to Prohibix LLC by National Heart Lung and Blood Institute (National Institutes of Health) on July 15, 2020.

How much is award R44HL140645 worth?

$4,323,444 has been obligated on R44HL140645: $3,200,596 in federal funding and $1,122,848 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award